Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

53
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
53
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

1.4K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

113
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
113
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

117
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
117
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

313
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
313
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

440
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
440

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare utilization and HIV burden among Black communities in Ontario: a matched cohort study.

Canadian journal of public health = Revue canadienne de sante publique·2026
Same author

Dying younger, dying of overdose: gendered and age dimensions of mortality and shelter service access among individuals experiencing homelessness in Toronto, Canada.

BMC public health·2026
Same author

Association between early methadone dose titration and treatment discontinuation and opioid toxicity: A retrospective cohort study.

PLoS medicine·2026
Same author

Patient and Prescriber characteristics associated with return to daily-dispense methadone: A multilevel cohort study.

PLOS mental health·2026
Same author

Shifting views on decriminalization in British Columbia: insights from public opinion polling, 2024-2025.

The American journal of drug and alcohol abuse·2026
Same author

Trends in fentanyl-containing drug samples seized by law enforcement agencies across Canada.

Addiction (Abingdon, England)·2026

Related Experiment Video

Updated: Mar 13, 2026

Assessment of Social Interaction Behaviors
06:41

Assessment of Social Interaction Behaviors

Published on: February 25, 2011

95.6K

Process evaluation of the Prevent Overdose in Toronto (POINT) program.

Pamela Leece1, Margaret Gassanov, Shaun Hopkins

  • 1Dalla Lana School of Public Health, University of Toronto, Toronto, ON. pamela.leece@mail.utoronto.ca.

Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|October 21, 2016
PubMed
Summary

The Prevent Overdose in Toronto (POINT) program trained 662 individuals in opioid overdose prevention, with 98 naloxone administrations reported, leading to high survival rates and positive feedback for program improvement.

More Related Videos

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

26.4K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.4K

Related Experiment Videos

Last Updated: Mar 13, 2026

Assessment of Social Interaction Behaviors
06:41

Assessment of Social Interaction Behaviors

Published on: February 25, 2011

95.6K
Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

26.4K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.4K

Area of Science:

  • Public Health
  • Harm Reduction
  • Addiction Medicine

Background:

  • Opioid overdose remains a significant public health crisis.
  • Effective harm reduction strategies are crucial for saving lives.
  • Community-based programs play a vital role in overdose prevention.

Purpose of the Study:

  • To evaluate the initial two years of the Prevent Overdose in Toronto (POINT) program.
  • To assess the program's reach, effectiveness, and client/stakeholder satisfaction.
  • To identify areas for improvement in opioid overdose prevention and response.

Main Methods:

  • Process evaluation of the POINT program (August 2011-2013).
  • Analysis of program documentation and qualitative interviews with staff, partners, and clients.
  • Data collection on training participants, opioid use, and naloxone administration.

Main Results:

  • 662 individuals trained in opioid overdose prevention and received naloxone kits.
  • Most common opioids used were oxycodone (40.4%) and heroin (34.4%).
  • 98 naloxone administrations reported, with high survival rates (one fatality, one unknown).
  • High satisfaction reported by staff, partners, and clients regarding program reach and training.
  • Suggestions for improving recruitment and delivery were provided.

Conclusions:

  • The POINT program successfully engaged at-risk individuals in overdose prevention and response.
  • Naloxone use in overdose events was reported, with positive survival outcomes.
  • Program evaluation findings are informing improvements to POINT and broader public health practices in opioid overdose prevention.